Fig. 10From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinomaThe evaluation of the selected chemotherapy drugs between high- and low-ARGs signature score groups. (*p < 0.05, **p < 0.01, ****p < 0.0001)Back to article page